v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Apr. 04, 2026
Mar. 29, 2025
Cash flows from operating activities    
Net income $ 220 $ 207
Non-cash items:    
Depreciation and amortization 96 92
Deferred income taxes 44 (22)
Other, net 42 41
Changes in assets and liabilities:    
Accounts receivable, net (61) 16
Inventories (289) (183)
Other assets (104) (136)
Accounts payable 162 171
Other liabilities (148) (282)
Income taxes, net (5) 39
Pension, net (60) (59)
Captive finance receivables, net (13) (13)
Other operating activities, net (1) 5
Net cash provided by (used in) operating activities (117) (124)
Cash flows from investing activities    
Capital expenditures (133) (56)
Net proceeds from corporate-owned life insurance policies 1 31
Proceeds from sale of property, plant and equipment 2 0
Finance receivables repaid 7 9
Finance receivables originated (9) 0
Proceeds from the disposition of non-captive assets 24 0
Other investing activities, net 4 15
Net cash provided by (used in) investing activities (104) (1)
Cash flows from financing activities    
Proceeds from issuance of debt 0 495
Principal payments on long-term debt and nonrecourse debt (74) (355)
Purchases of Textron common stock (168) (215)
Proceeds from stock options exercised 56 6
Dividends paid (3) (3)
Other financing activities, net (4) (6)
Net cash used in financing activities (193) (78)
Effect of exchange rate changes on cash and equivalents (1) 7
Net increase (decrease) in cash and equivalents (415) (196)
Cash and equivalents at beginning of period 2,025 1,441
Cash and equivalents at end of period $ 1,610 $ 1,245